JPH07289863A - Polysulfone hollow fiber membrane and its production - Google Patents

Polysulfone hollow fiber membrane and its production

Info

Publication number
JPH07289863A
JPH07289863A JP6110165A JP11016594A JPH07289863A JP H07289863 A JPH07289863 A JP H07289863A JP 6110165 A JP6110165 A JP 6110165A JP 11016594 A JP11016594 A JP 11016594A JP H07289863 A JPH07289863 A JP H07289863A
Authority
JP
Japan
Prior art keywords
hollow fiber
fiber membrane
membrane
polysulfone
hydrophilic polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6110165A
Other languages
Japanese (ja)
Other versions
JP3714686B2 (en
Inventor
Masatoshi Kamisaka
正利 上坂
Yoshikazu Taniguchi
義和 谷口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd, Asahi Chemical Industry Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP11016594A priority Critical patent/JP3714686B2/en
Publication of JPH07289863A publication Critical patent/JPH07289863A/en
Application granted granted Critical
Publication of JP3714686B2 publication Critical patent/JP3714686B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PURPOSE:To prepare a membrane excellent in anti-thrombus property and adaptability for blood with which blood protein of high mol.wt. can be removed by constituting the hollow fiber membrane of a polysulfone resin and a hydrophilic polymer and forming a dense active layer in the inner surface side of the membrane and forming pores having specified properties in the outer surface side. CONSTITUTION:This hollow fiber membrane consists of a polysulfone resin and a hydrophilic polymer such as polyvinylpyrolidone. The hollow fiber membrane has a dense active layer in the inner surface side and has pores of 0.3-20mum average pore diameter in the outer surface side. The membrane has such properties that the porosity on the outer surface is 20-50%, the inside of the membrane contains no microvoid of >=5mum size, the screening coefft. for albumen albumin is >=0.2, and water permeability is 100 to 500ml/ hr.m<2>.mmHg. This hollow fiber membrane has low permeability for albumin although protein in 20000-40000mol.wt. range can be removed with this membrane.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はポリスルホン系中空糸膜
に関するものであり、特に医療用に好適に用いられる血
液透析用の中空糸膜及びその製法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a polysulfone-based hollow fiber membrane, and more particularly to a hemodialysis hollow fiber membrane preferably used for medical purposes and a method for producing the same.

【0002】[0002]

【従来の技術】腎不全の治療のために現在各種の人工腎
臓が使用されているが、これらは中空糸膜を用いて血液
透析や血液濾過を行い尿素等の血液中の老廃物を除去す
ることを目的としている。従って、血液は膜と接触しな
ければならないために生体に対して安全な素材を用いな
ければならず、例えばこれまではセルロ−ス、セルロ−
スアセテ−ト、ポリアクリロニトリル、ポリメチルメタ
クリレ−ト、メチレン−ビニルアルコ−ル共重合体等が
広く用いられてきている。また、最近ではポリスルホン
を主たる素材とした中空糸膜が注目されており、特公平
2−18695号公報、特公平5−54373号公報、
特公平3−267128号公報にその技術的開示がなさ
れている。
2. Description of the Related Art Various artificial kidneys are currently used for the treatment of renal failure. These are used for hemodialysis and hemofiltration using a hollow fiber membrane to remove urea and other waste products in the blood. Is intended. Therefore, since blood must come into contact with the membrane, it is necessary to use a material that is safe for the living body. For example, until now, cellulose and cellulose have been used.
Suacetate, polyacrylonitrile, polymethylmethacrylate, methylene-vinyl alcohol copolymer and the like have been widely used. Further, recently, a hollow fiber membrane mainly made of polysulfone has attracted attention, and Japanese Patent Publication Nos. 2-18695 and 5-54373,
The technical disclosure is disclosed in Japanese Examined Patent Publication No. 3-267128.

【0003】しかしながら、前記公報の膜では血液透析
用の膜とするには不十分であり、例えば、特公平2−1
8695号公報に開示の中空糸膜の場合、中空糸膜間の
固着が激しくモジュ−ルが成型できなかったり、特公平
5−54373号公報に開示の膜は分画分子量が300
0から40,000でしかないため、20,000〜4
0,000の分子量領域の蛋白を除去することが求めら
れている透析治療技術の現状では不満足な膜でしかな
い。また、特公平3−267128号公報に開示の膜は
透水量が高く、孔径も大きすぎるためにもはや血液透析
用の膜として使用することはできない。
However, the membrane disclosed in the above publication is not sufficient as a membrane for hemodialysis. For example, Japanese Patent Publication No. 2-1
In the case of the hollow fiber membranes disclosed in Japanese Patent No. 8695, the hollow fiber membranes are firmly fixed to each other and a module cannot be molded, or the membrane disclosed in Japanese Patent Publication No. 5-54373 has a molecular weight cutoff of 300.
Since it is only 0 to 40,000, 20,000 to 4
At present, the dialysis treatment technology required to remove proteins in the molecular weight range of 10,000 is only an unsatisfactory membrane. Further, the membrane disclosed in Japanese Patent Publication No. 3-267128 cannot be used as a membrane for hemodialysis because it has a high water permeability and a too large pore size.

【0004】[0004]

【発明が解決しようとする課題】本発明は抗血栓性、血
液適合性に優れ、さらには高分子量の血液蛋白を除去で
きる人工腎臓用のポリスルホン系中空糸膜を提供し、血
液透析治療技術の向上に寄与するものである。
DISCLOSURE OF THE INVENTION The present invention provides a polysulfone-based hollow fiber membrane for an artificial kidney, which is excellent in antithrombogenicity and blood compatibility, and is capable of removing high-molecular weight blood proteins. It contributes to the improvement.

【0005】[0005]

【課題を解決する手段】抗血栓性、血液適合性を有し、
分画分子量の大きいポリスルホン系中空糸膜を提供する
ために本発明者らは鋭意検討の結果本発明を完成するに
至ったものである。即ち、ポリスルホン系樹脂と親水性
高分子からなる中空糸膜であって、該中空糸膜の内表面
側には緻密な活性層を、また外表面側には平均孔径0.
3〜2.0μの孔を有し、該外表面における孔の開孔率
は20〜50%であって、かつ膜内部には5μ以上のマ
クロボイドを有さず、卵白アルブミンの篩い係数が0.
2以上、かつ透水量が100〜500ml/hr・m2
・mmHgであることを特徴とするポリスルホン系中空
糸膜であり、以下に本発明を詳細に説明する。
[Means for Solving the Problems] Having antithrombotic properties and blood compatibility,
The present inventors have completed the present invention as a result of intensive studies to provide a polysulfone-based hollow fiber membrane having a large molecular weight cutoff. That is, a hollow fiber membrane composed of a polysulfone-based resin and a hydrophilic polymer, wherein a dense active layer is formed on the inner surface side of the hollow fiber membrane and an average pore diameter of 0.
The pores on the outer surface have a porosity of 20 to 50%, the inside of the membrane does not have macrovoids of 5 μ or more, and the sieving coefficient of ovalbumin is 0.
2 or more and water permeability of 100-500 ml / hr · m 2
It is a polysulfone-based hollow fiber membrane characterized by having mmHg, and the present invention will be described in detail below.

【0006】ポリスルホン系樹脂とはスルホン結合を有
する高分子化合物の総称であり特に規定するものではな
いが、例をあげると下記(1)式または(2)式で示さ
れるポリスルホン樹脂が広く市販されており入手も容易
なため好ましく、中でも(1)式で示される化学構造を
持つポリスルホン樹脂がよい。この構造を持つポリスル
ホン樹脂はアモコ・パフォ−マンス・プロダクツより
「ユ−デル」の商標名で市販されており、重合度等によ
っていくつかの種類が存在するが特にこだわらない。
The polysulfone-based resin is a general term for polymer compounds having a sulfone bond and is not particularly defined. However, for example, the polysulfone resin represented by the following formula (1) or (2) is widely commercially available. The polysulfone resin having the chemical structure represented by the formula (1) is preferable because it is easily available. The polysulfone resin having this structure is commercially available from Amoco Performance Products under the trade name of "Uder", and there are several kinds depending on the degree of polymerization, but there is no particular restriction.

【0007】[0007]

【化1】 [Chemical 1]

【0008】また、親水性高分子としてはポリビニルピ
ロリドン、ポリエチレングリコ−ル、ポリエチレンイミ
ン、ポリアクリル酸等の親水性を有する高分子が使用で
きるがポリスルホン系樹脂に対する親和性がよいことか
らポリビニルピロリドン、ポリエチレングリコ−ルが好
ましく用いられ、中でもポリビニルピロリドンが最も好
ましく使用される。
As the hydrophilic polymer, polymers having hydrophilicity such as polyvinylpyrrolidone, polyethylene glycol, polyethyleneimine and polyacrylic acid can be used, but polyvinylpyrrolidone, which has a good affinity for polysulfone resin, Polyethylene glycol is preferably used, and polyvinylpyrrolidone is most preferably used.

【0009】本発明における中空糸膜の製膜に際しては
従来より一般的に知られている技術である乾湿式製膜技
術が使用でき、乾湿式製膜を行うための製膜原液として
はポリスルホン系樹脂、親水性高分子、溶剤及び/また
は非溶剤からなる均一に溶解した高分子溶液を用いる。
In forming the hollow fiber membrane in the present invention, a dry-wet film forming technique which is a generally known technique can be used, and a polysulfone-based solution is used as a film forming stock solution for performing the dry-wet film forming. A uniformly dissolved polymer solution containing a resin, a hydrophilic polymer, a solvent and / or a non-solvent is used.

【0010】該製膜原液を作成するにはポリスルホン系
樹脂と親水性高分子の両者に対して共通に溶解性を有す
る溶剤が使用され、特に規定するものではないが例をあ
げるとN,N−ジメチルアセトアミド、N,N−ジメチ
ルフォルムアミド、N−メチルピロリドン、ジメチルス
ルフォキシド等の溶剤が溶解性も高く、入手も容易であ
るため好適に使用される。中でもポリスルホンに対する
溶解性の高さ、生体に対する安全性等からN,N−ジメ
チルアセトアミド、N−メチルピロリドンがよく、中で
もN,N−ジメチルアセトアミドが最も好ましく用いら
れる。また、これらの溶剤は単独で使用する必要はな
く、ポリマ−に対する溶解性を調整し製膜原液の粘度を
調整する等の目的を持って2種あるいはそれ以上の溶剤
を混合して用いることもできる。さらには水やイソプロ
ピルアルコ−ル、エタノ−ル等のアルコ−ル類、塩化ナ
トリウム、塩化カルシウム等の無機塩類、プロピレング
リコ−ル、テトラエチレングリコ−ル等のグリコ−ル類
などの非溶剤を添加することも可能であり、こうするこ
とによって膜性状を変えることができることから膜性能
をコントロ−ルするためには有利な方法となる。その添
加量、種類については目的とする中空糸膜の性状に応じ
て適宜選択していけばよい。
A solvent having a common solubility for both the polysulfone-based resin and the hydrophilic polymer is used for preparing the membrane-forming stock solution, and although not particularly specified, examples include N, N. Solvents such as -dimethylacetamide, N, N-dimethylformamide, N-methylpyrrolidone and dimethylsulfoxide have high solubility and are easily available, and thus are preferably used. Among them, N, N-dimethylacetamide and N-methylpyrrolidone are preferable because of their high solubility in polysulfone and safety against living organisms, and among them, N, N-dimethylacetamide is most preferably used. Further, these solvents do not have to be used alone, and two or more kinds of solvents may be mixed for the purpose of adjusting the solubility in the polymer and the viscosity of the film forming solution. it can. Furthermore, non-solvents such as water, alcohols such as isopropyl alcohol and ethanol, inorganic salts such as sodium chloride and calcium chloride, glycols such as propylene glycol and tetraethylene glycol are used. It is also possible to add, and by doing so, the film properties can be changed, which is an advantageous method for controlling the film performance. The amount and type of addition may be appropriately selected according to the intended properties of the hollow fiber membrane.

【0011】該ポリスルホン系樹脂の添加量は少なすぎ
ると膜の形成が困難となり膜強度が弱くなりすぎてしま
ったり、多すぎると紡糸性が悪く孔径が小さくなりすぎ
る等の現象が生じてくるため15〜20重量%、中でも
16〜18重量%であることが好ましい。しかしこの範
囲であることが絶対ではなく目的とする中空糸膜の性状
によってはこの範囲より小さくすることも大きくするこ
ともでき、他の紡糸条件を変化させることによっても膜
性状は変化するので、最適な組み合わせを適宜選択すれ
ばよい。該親水性高分子としてはポリビニルピロリド
ン、ポリエチレングリコ−ル、ポリエチレンイミン、ポ
リアクリル酸等の親水性を有する高分子化合物が使用さ
れるが、必ずしも単独で使用する必要性はなく数種の親
水性高分子を混合して添加することもできる。
If the amount of the polysulfone-based resin added is too small, the formation of a film becomes difficult and the film strength becomes too weak, and if it is too large, the spinnability deteriorates and the pore size becomes too small. It is preferably 15 to 20% by weight, and more preferably 16 to 18% by weight. However, it is not absolutely in this range and can be made smaller or larger than this range depending on the properties of the target hollow fiber membrane, and since the membrane properties also change by changing other spinning conditions, The optimum combination may be selected as appropriate. As the hydrophilic polymer, hydrophilic polymer compounds such as polyvinylpyrrolidone, polyethylene glycol, polyethyleneimine and polyacrylic acid are used, but it is not always necessary to use them alone and several hydrophilic compounds are used. Polymers may be mixed and added.

【0012】製膜原液への親水性高分子の添加量は親水
性高分子の種類や親水性高分子の分子量によっては最適
な添加領域が変化してくるために一概には決められない
が、一般的には3〜30%であり、親水性高分子がポリ
ビニルピロリドンであるときには3〜20重量%が好ま
しく、さらに好ましくは3〜15重量%である。ポリビ
ニルピロリドンは下記(3)式の構造を有する水溶性の
高分子化合物でありアイ・エス・ピ−より「プラスド
ン」の商標で、またビ−・エ−・エス・エフより「コリ
ドン」の商標で市販されておりそれぞれいくつかの分子
量のポリビニルピロリドンがある。
The addition amount of the hydrophilic polymer to the stock solution for film formation cannot be unconditionally determined because the optimum addition region varies depending on the kind of the hydrophilic polymer and the molecular weight of the hydrophilic polymer. Generally, it is 3 to 30%, and when the hydrophilic polymer is polyvinylpyrrolidone, it is preferably 3 to 20% by weight, more preferably 3 to 15% by weight. Polyvinylpyrrolidone is a water-soluble polymer compound having a structure represented by the following formula (3), which is a trademark of "Plasdone" from IS-P and a trademark of "Kolidone" from BSF. There are several molecular weight polyvinylpyrrolidones, each of which is commercially available at.

【0013】[0013]

【化2】 [Chemical 2]

【0014】親水性高分子を製膜原液へ添加する目的は
中空糸膜内に親水性高分子を残存させて膜に親水性を付
与することであるので、その分子量の選択は極めて重要
なことである。というのも親水性高分子の分子量が小さ
すぎると製膜原液の凝固時、及び得られた中空糸膜の洗
浄時に該親水性高分子は容易に膜内から出てきてしまう
ため、中空糸膜に親水性を付与するに充分な親水性高分
子を中空糸膜中に残存させるためには多量の親水性高分
子を製膜原液へ添加しなければならないからである。従
って、親水性高分子の中空糸膜中への残存率を高めるた
めには分子量は大きい方がよく、そのことによって製膜
原液に添加した親水性高分子は有効に活用でき、添加量
を少なくできるので好ましい。
Since the purpose of adding the hydrophilic polymer to the stock solution for membrane formation is to impart hydrophilicity to the membrane by leaving the hydrophilic polymer in the hollow fiber membrane, selection of its molecular weight is extremely important. Is. If the molecular weight of the hydrophilic polymer is too small, the hydrophilic polymer will easily come out of the membrane during coagulation of the membrane-forming stock solution and during washing of the obtained hollow fiber membrane. This is because a large amount of hydrophilic polymer must be added to the membrane-forming stock solution in order to leave sufficient hydrophilic polymer in the hollow fiber membrane to impart hydrophilicity thereto. Therefore, in order to increase the residual rate of the hydrophilic polymer in the hollow fiber membrane, it is preferable that the molecular weight is large, which allows the hydrophilic polymer added to the membrane forming stock solution to be effectively utilized and the addition amount to be reduced. It is preferable because it is possible.

【0015】親水性高分子がポリビニルピロリドンであ
る時にも分子量は大きい方が好ましく、例えば500,
000以上の粘度平均分子量を有するポリビニルピロリ
ドンを使用するときには3〜6重量%であることがよ
い。中空糸膜を製膜するに際してはチュ−ブインオリフ
ィス型の二重紡口を用い、該紡口から製膜原液と該製膜
原液を凝固させる為の中空内液とを同時に空中に押し出
し、20〜50cmの空走部を走行させた後、紡口下部
に設置した水を主体とする凝固浴中へ浸漬、凝固させた
後巻きとってやればよい。
Even when the hydrophilic polymer is polyvinylpyrrolidone, it is preferable that the molecular weight is large, for example, 500,
When polyvinylpyrrolidone having a viscosity average molecular weight of 000 or more is used, it is preferably 3 to 6% by weight. When forming a hollow fiber membrane, a tube-in-orifice double spinneret is used, and a film-forming stock solution and a hollow liquid for coagulating the film-forming stock solution are simultaneously extruded into the air, and After running in an idle section of up to 50 cm, it may be dipped in a coagulation bath mainly composed of water installed in the lower part of the spinneret to coagulate and then wound.

【0016】この時重要なことは該製膜原液の粘度を
1,500〜6,000センチポイズ、とりわけ3,5
00〜5,000センチポイズとなる状態で製膜を行う
ことである。高分子溶液の粘度はその組成や温度などに
より変わることはよく知られたことであるが、製膜原液
の粘度をこの範囲内におさえるためには加温、または冷
却してやればよい。すなわちここで言うところの粘度と
は一律的に規定した条件での粘度ではなく、要するに製
膜条件下に於いて原液粘度をコントロ−ルすることが重
要であり、該粘度が1,500〜6,000センチポイ
ズとなるような条件範囲を設定してやればよい。
At this time, it is important to adjust the viscosity of the stock solution for film formation to 1,500 to 6,000 centipoise, especially 3,5.
It is to carry out film formation in a state of being 00 to 5,000 centipoise. It is well known that the viscosity of the polymer solution changes depending on its composition, temperature, etc., but heating or cooling may be carried out in order to keep the viscosity of the stock solution for film formation within this range. That is, the term "viscosity" as used herein is not a viscosity under uniformly defined conditions, but it is important to control the viscosity of the undiluted solution under film forming conditions. It suffices to set the condition range so as to obtain 1,000 centipoise.

【0017】その理由についてはよくわからないが、粘
度が低い状態の製膜原液を用いて中空糸膜の製膜を行う
と膜内部に5μよりも大きなマクロボイドが顕著に現れ
るようになるが、血液透析用の中空糸膜の場合にこうし
たマクロボイドが多数存在すると血液中の血小板の活性
化が激しくなり、人工腎臓としたときに安定な血液透析
療法が出来なくなってしまう。従って、血液透析に用い
る中空糸膜に於いてはマクロボイドが無いことが好まし
く、そのためには原液粘度が1,500センチポイズ以
上の状態で製膜することが好ましい。ここでいうマクロ
ボイドとは膜内部でポリマ−が存在しない空孔部のうち
その最大径が5μ以上のものを言う。一方、原液粘度が
高くなりすぎると紡糸性が悪くなり糸切れ等が多発して
くるために6,000センチポイズを越えない粘度状態
の原液を使用するのがよい。
Although the reason for this is not clear, when a hollow fiber membrane is formed from a stock solution having a low viscosity, macrovoids larger than 5μ will appear in the membrane, but In the case of a hollow fiber membrane for dialysis, the presence of a large number of such macrovoids makes the activation of platelets in the blood so strong that a stable hemodialysis treatment cannot be performed when an artificial kidney is used. Therefore, it is preferable that the hollow fiber membrane used for hemodialysis does not have macrovoids, and for that purpose, it is preferable to form the membrane in a state where the stock solution viscosity is 1,500 centipoise or more. The term "macrovoid" as used herein refers to a hole portion having no polymer inside the film and having a maximum diameter of 5 µm or more. On the other hand, if the viscosity of the stock solution becomes too high, the spinnability deteriorates and thread breakage and the like frequently occur. Therefore, it is preferable to use a stock solution in a viscosity state not exceeding 6,000 centipoise.

【0018】さらに重要なのは空走部の雰囲気であり、
二重紡口より押し出されて凝固を始めた中空糸膜が走行
する雰囲気の絶対湿度を0.02〜0.3kg・H2
/kg・乾燥空気とすることであり、空走部の湿度雰囲
気をこの範囲の湿度状態に設定することにより、中空糸
膜の外表面の開孔率を高くすることができ中空糸膜間の
固着を防ぐことが可能となり、モジュ−ルへの成型性を
向上させるのに対して大きな効果を発揮する。
More important is the atmosphere of the empty running section,
The absolute humidity of the atmosphere in which the hollow fiber membrane extruded from the double spinneret and started to coagulate runs from 0.02 to 0.3 kg · H 2 O
/ Kg · dry air, and by setting the humidity atmosphere in the idle section to a humidity condition within this range, the open area ratio of the outer surface of the hollow fiber membrane can be increased. It becomes possible to prevent sticking, and exerts a great effect on improving moldability into a module.

【0019】その理由については詳しくはわからない
が、二重紡口より吐出された中空糸状の製膜原液の外表
面に対して空走部の水蒸気が接触し製膜原液の凝固が誘
発され、凝固浴中で凝固が完全に終了するまでの間にお
いても緩やかに凝固が進行する。その結果、紡口より吐
出された中空糸状の製膜原液の外表面においては相分離
が進行した状態、すなわちポリマ−高濃度相とポリマ−
低濃度相に分離した状態で凝固浴中に浸漬され凝固が終
了するためにポリマ−低濃度相が空孔になると考えられ
る。さらに好ましくは0.04〜0.20kg・H2
/kg・乾燥空気とするのがよいが、高湿度化するため
にはフ−ド等によって空走部を外界と遮断し、該遮断さ
れたフ−ド内に飽和水蒸気を吹き込んだり、凝固浴の温
度を上げることで発生する水蒸気をフ−ド内に充満させ
る等によって達成できる。
Although the reason for this is not known in detail, the water vapor in the idle portion comes into contact with the outer surface of the hollow fiber membrane-forming raw material solution discharged from the double spinneret to induce coagulation of the membrane-forming raw material solution and to cause coagulation. The coagulation proceeds slowly even before the coagulation is completely completed in the bath. As a result, on the outer surface of the hollow fiber membrane-forming stock solution discharged from the spinneret, a state in which phase separation has progressed, that is, the polymer high-concentration phase and the polymer
It is considered that the polymer-low-concentration phase becomes voids because the polymer-low-concentration phase is immersed in the coagulation bath in a state where it is separated into the low-concentration phase and the coagulation is completed. More preferably 0.04 to 0.20 kg · H 2 O
/ Kg · dry air is preferable, but in order to increase the humidity, the idle part is shielded from the outside by a hood, etc., and saturated steam is blown into the shielded hood, or a coagulation bath is used. This can be achieved by filling the hood with water vapor generated by raising the temperature.

【0020】中空内液は水、または水を主体とした凝固
液が使用でき、目的とする中空糸膜の膜性能に応じてそ
の組成等は適宜決めていけばよく一概には決められない
が、一般的には製膜原液の作成に使った溶剤と水との混
合溶液が好適に使用される。例えば20〜60重量%の
N,N−ジメチルアセトアミド水溶液などが用いられる
が、特に35〜50重量%がよい。また、該中空内液に
親水性高分子水溶液を使用することもできる。製膜され
た中空糸膜は洗浄後巻取り、必要に応じてグリセリン,
ポリエチレングリコ−ル等の孔径保持剤を付与させて後
乾燥し、乾燥膜として得ることが出来る。
Water or a coagulating liquid mainly composed of water can be used as the hollow liquid, and the composition and the like may be appropriately determined depending on the desired membrane performance of the hollow fiber membrane, but cannot be determined unconditionally. Generally, a mixed solution of the solvent and water used for preparing the film-forming stock solution is preferably used. For example, an aqueous solution of 20 to 60% by weight of N, N-dimethylacetamide is used, but 35 to 50% by weight is particularly preferable. Further, a hydrophilic polymer aqueous solution can be used as the hollow liquid. The hollow fiber membrane formed is washed and wound up, and if necessary, glycerin,
A pore size-retaining agent such as polyethylene glycol may be applied and then dried to obtain a dry film.

【0021】本発明によって得られた中空糸膜は膜の内
表面に緻密層を有していながら、膜の外表面側には0.
3〜2.0μの大きさの孔を20〜50%の開孔率で有
していた。緻密な層を外表面側に有する中空糸膜や、あ
るいは開孔がみられても孔が小さかったり、開孔率が小
さい中空糸膜の場合には中空糸膜間の固着が激しく、人
工腎臓モジュ−ルを成型するときのポッティング材によ
る封入が不充分であったことより、その理由については
よくわからないが中空糸膜の固着を防ぎポッティング材
による封入を容易にする点で外表面の構造は大きな意味
を持つものである。
The hollow fiber membrane obtained by the present invention has a dense layer on the inner surface of the membrane, but has a density of 0.
It had pores with a size of 3 to 2.0 μ and a porosity of 20 to 50%. A hollow fiber membrane having a dense layer on the outer surface side, or a hollow fiber membrane with small pores even if there are pores, or a hollow fiber membrane with a low porosity, the fixation between the hollow fiber membranes is severe and the artificial kidney Although the reason for this is not well understood because the encapsulation by the potting material when molding the module was insufficient, the structure of the outer surface is in terms of preventing the hollow fiber membrane from sticking and facilitating the encapsulation by the potting material. It has a big meaning.

【0022】一方、膜孔径が2.0μより大きく、開孔
率が50%より大きくなると中空糸膜の強度が弱くなり
取り扱いにくい中空糸になるばかりでなく、蛋白の透過
率が高くなりすぎて血液透析用の中空糸膜としては不適
当になってしまうので好ましくない。ここでの孔の大き
さは画像処理により個々の孔の開孔面積を求めた後、こ
の面積を円とみなして換算した直径をいい、平均孔径と
は個々の孔の大きさとその数より算術平均した孔径をい
う。すなわち、N個の孔の孔径をそれぞれD1,D2,
・・・DNとしたとき、平均孔径は下記の(4)式で算
出される。また開孔率は単位面積中に存在する1個1個
の孔の開孔面積の総和として表される。 平均孔径=(D1+D2+・・・+DN)/N ・・・・・(4) また、本発明により得られる中空糸膜は分画分子量が約
50,000と大きくしてあるため通常の血液透析膜で
は除去が困難な大分子量の不要蛋白までも除去が可能と
なる。
On the other hand, when the membrane pore diameter is larger than 2.0 μ and the open area ratio is larger than 50%, not only the hollow fiber membrane becomes weak and the hollow fiber becomes difficult to handle, but also the protein permeability becomes too high. It is not preferable because it becomes unsuitable as a hollow fiber membrane for hemodialysis. The hole size here is the diameter calculated by calculating the open area of each hole by image processing and then considering this area as a circle, and the average hole diameter is calculated from the size of each hole and its number. The average pore size. That is, the diameters of the N holes are D1, D2, and
The average pore size is calculated by the following equation (4), where DN is set. The open area ratio is expressed as the sum of the open area of each hole existing in a unit area. Average pore size = (D1 + D2 + ... + DN) / N (4) Further, since the hollow fiber membrane obtained by the present invention has a large molecular weight cutoff of about 50,000, it is a normal hemodialysis membrane. With this, it is possible to remove even large molecular weight unwanted proteins that are difficult to remove.

【0023】本発明による中空糸膜の場合、外表面には
0.3〜2.0μの大きな孔を有しているにもかかわら
ず、内表面には緻密な活性層を持たせているために血中
の総蛋白に対する血中アルブミンの透過率は5%以下で
あり、しかも凝固条件を適切に制御することで卵白アル
ブミンの様な比較的大きな分子量の物質を透過させるこ
とが可能となったために、血中の20,000〜40,
000の分子量を有する不要蛋白の除去ができ、長期透
析に伴う種々の合併症を防ぐ上で大きな効果を発揮する
事ができ、透析医療技術の向上に大きな貢献をするもの
である。なお、本発明は血液透析等の医療用の膜素材と
してだけではなく、各種の工業用の膜として使用しても
よいことはもちろんである。
In the hollow fiber membrane according to the present invention, the outer surface has large pores of 0.3 to 2.0 μ, but the inner surface has a dense active layer. In addition, the permeability of blood albumin to the total protein in blood is less than 5%, and by controlling the coagulation conditions appropriately, it became possible to permeate a relatively large molecular weight substance such as ovalbumin. 20,000 to 40 in blood,
Unnecessary protein having a molecular weight of 000 can be removed, and a great effect can be exerted in preventing various complications associated with long-term dialysis, which greatly contributes to improvement of dialysis medical technology. The present invention may be used not only as a membrane material for medical use such as hemodialysis but also as a membrane for various industrial uses.

【0024】[0024]

【実施例】以下に実施例および参考例を用いて本発明を
詳細に説明する。 (実施例1)ポリスルホン樹脂(アモコ・パフォ−マン
ス・プロダクツ,P−1700)18部、ポリビニルピ
ロリドン(アイ・エス・ピ−,K−90)5部、N,N
−ジメチルアセトアミド77部からなる均一な製膜原液
を作成した。40重量%のN,N−ジメチルアセトアミ
ド水溶液を中空内液とし、前記製膜原液を45℃の状態
(3,800センチポイズ)として同時に二重紡口から
押し出し、外界から遮断するためにとりつけたフ−ドの
中を通って30cm下方に設けた50℃の水中に浸漬し
50m/minの速度で巻取った。この時、フ−ドの中
は凝固浴からの水蒸気のため高湿度となっており、絶対
湿度を実測したところ0.05kg・H2 O/kg・乾
燥空気であった。得られた中空糸膜は20重量%のグリ
セリン水溶液で処理した後、75℃で乾燥し評価を行っ
た。この膜の外表面の平均孔径は1.1μで、開孔率は
35%であった。
EXAMPLES The present invention will be described in detail below with reference to examples and reference examples. (Example 1) 18 parts of polysulfone resin (Amoco Performance Products, P-1700), 5 parts of polyvinylpyrrolidone (IPS, K-90), N, N
A uniform film-forming stock solution was prepared, which consisted of 77 parts of dimethylacetamide. A 40% by weight aqueous solution of N, N-dimethylacetamide was used as a hollow liquid inside, and the stock solution for film formation was simultaneously extruded from a double spinneret in a state of 45 ° C. (3,800 centipoise) and attached to shut off from the outside. It was dipped in water at 50 ° C., which was provided 30 cm downward through the inside of the container, and was wound at a speed of 50 m / min. At this time, the hood had high humidity due to water vapor from the coagulation bath, and the absolute humidity was measured and found to be 0.05 kg · H 2 O / kg · dry air. The obtained hollow fiber membrane was treated with a 20 wt% glycerin aqueous solution and then dried at 75 ° C. for evaluation. The average pore diameter of the outer surface of this membrane was 1.1 μ, and the open area ratio was 35%.

【0025】(参考例1)空走部のフ−ドをはずした以
外は実施例1と同様の条件で紡糸を行った。この時の空
走部の絶対湿度は0.016kg・H2 O/kg・乾燥
空気であった。中空糸膜を実施例1と同様の処理を行い
乾燥した。外表面の平均孔径0.2μ、開孔率16%の
中空糸膜であった。
Reference Example 1 Spinning was carried out under the same conditions as in Example 1 except that the hood of the idle running portion was removed. At this time, the absolute humidity of the idle portion was 0.016 kg · H 2 O / kg · dry air. The hollow fiber membrane was treated in the same manner as in Example 1 and dried. It was a hollow fiber membrane having an average pore diameter of 0.2 μm on the outer surface and an opening ratio of 16%.

【0026】(実施例2)実施例1で得られた中空糸膜
9,500本を円筒型の樹脂ケ−スに挿入し、遠心成型
法により750回転でポリウレタンをポッティングし
た。ポリウレタンは中空糸膜間に封入されており問題な
く成型でき、収率も満足できるものであった。 (参考例2)参考例1で得られた中空糸膜を用いる以外
は実施例2と同一の条件で遠心成型を行ったがポリウレ
タンは中空糸膜間には封入されておらず、収率は極めて
低かった。成型収率を表1に示した。
(Example 2) 9,500 hollow fiber membranes obtained in Example 1 were inserted into a cylindrical resin case, and polyurethane was potted at 750 rpm by a centrifugal molding method. Polyurethane was enclosed between the hollow fiber membranes and could be molded without problems, and the yield was satisfactory. Reference Example 2 Centrifugal molding was performed under the same conditions as in Example 2 except that the hollow fiber membrane obtained in Reference Example 1 was used, but polyurethane was not enclosed between the hollow fiber membranes and the yield was It was extremely low. The molding yield is shown in Table 1.

【0027】[0027]

【表1】 [Table 1]

【0028】(実施例3)実施例1で得られた中空糸膜
100本からなるミニモジュ−ル(有効長25cm)を
作成し、200mmHgの圧力条件のもとストップ法に
て透水量を測定した。その後、卵白アルブミンの250
ppm水溶液をミニモジュ−ルに通液し卵白アルブミン
の篩い係数を測定した。なお、卵白アルブミン篩い係数
は280nmで測定した元液中の卵白アルブミン濃度と
濾液中の卵白アルブミン濃度より次の(5)式を用いて
算出した値である。 篩い係数=濾液の卵白アルブミン濃度/元液の卵白アルブミン濃度・・・(5) 測定結果を表2に示した。
(Example 3) A mini-module (effective length 25 cm) consisting of 100 hollow fiber membranes obtained in Example 1 was prepared, and the water permeation amount was measured by the stop method under a pressure condition of 200 mmHg. . Then 250 of ovalbumin
The ppm aqueous solution was passed through a mini module to measure the sieving coefficient of ovalbumin. The ovalbumin sieving coefficient is a value calculated from the ovalbumin concentration in the original solution measured at 280 nm and the ovalbumin concentration in the filtrate using the following formula (5). Sieving coefficient = Ovalbumin concentration of filtrate / Ovalbumin concentration of original solution (5) The measurement results are shown in Table 2.

【0029】(参考例3)参考例1で得られた中空糸膜
を用いる以外は実施例3と同様にミニモジュ−ルを作成
し、透水量、及び卵白アルブミン篩い係数の測定を行っ
た。測定結果を表2に示した。
Reference Example 3 A mini-module was prepared in the same manner as in Example 3 except that the hollow fiber membrane obtained in Reference Example 1 was used, and the water permeability and the ovalbumin sieving coefficient were measured. The measurement results are shown in Table 2.

【0030】[0030]

【表2】 [Table 2]

【0031】(実施例4)実施例1の中空糸膜を用いて
実施例3と同様のミニモジュ−ルを作成した。200m
mHgの圧力下で牛血漿(総蛋白濃度5.5g)を通液
しながら濾過を行い、総蛋白に対するアルブミンの透過
率をみたところ0.9%と極わずかであり、実用上問題
のないレベルであった。
Example 4 Using the hollow fiber membrane of Example 1, a mini module similar to that of Example 3 was prepared. 200m
Filtration was performed while passing bovine plasma (total protein concentration 5.5 g) under the pressure of mHg, and the transmittance of albumin to the total protein was 0.9%, which was very small, which is a level with no practical problems. Met.

【0032】[0032]

【発明の効果】本発明の中空糸膜によれば分子量が2
0,000〜40,000の分子量領域の蛋白除去が可
能となるにもかかわらず、アルブミンも透過率が低いた
めに実用上の問題なく使用できることは明らかであり、
高分子量の蛋白除去が求められてくるこれからの透析治
療において非常に有意義な人工腎臓を提供することがで
きる。
The hollow fiber membrane of the present invention has a molecular weight of 2
Although it is possible to remove proteins in the molecular weight range of 50,000 to 40,000, it is clear that albumin can be used without any practical problems because of its low permeability.
It is possible to provide an artificial kidney that is very significant in the future dialysis treatments in which removal of high molecular weight proteins is required.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 D01F 6/76 D ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location D01F 6/76 D

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 ポリスルホン系樹脂と親水性高分子から
なる中空糸膜であって、該中空糸膜の内表面側には緻密
な活性層を、また外表面側には平均孔径0.3〜2.0
μの孔を有し、該外表面における孔の開孔率は20〜5
0%であって、かつ膜内部には5μ以上のマクロボイド
を有さず、卵白アルブミンの篩い係数が0.2以上、か
つ透水量が100〜500ml/hr・m2 ・mmHg
であることを特徴とするポリスルホン系中空糸膜。
1. A hollow fiber membrane comprising a polysulfone-based resin and a hydrophilic polymer, wherein a dense active layer is provided on the inner surface side of the hollow fiber membrane and an average pore diameter of 0.3-about. 2.0
The pore ratio of the pores on the outer surface is 20 to 5
It is 0% and does not have macrovoids of 5μ or more inside the membrane, the sieving coefficient of ovalbumin is 0.2 or more, and the water permeability is 100 to 500 ml / hr · m 2 · mmHg.
And a polysulfone-based hollow fiber membrane.
【請求項2】 親水性高分子がポリビニルピロリドンお
よび/またはポリエチレングリコ−ルであることを特徴
とする請求項1記載のポリスルホン系中空糸膜。
2. The polysulfone-based hollow fiber membrane according to claim 1, wherein the hydrophilic polymer is polyvinylpyrrolidone and / or polyethylene glycol.
【請求項3】 該ポリスルホン系中空糸膜に存在する親
水性高分子の含有率が3〜20%であることを特徴とす
る請求項1または2記載のポリスルホン系中空糸膜。
3. The polysulfone hollow fiber membrane according to claim 1 or 2, wherein the content of the hydrophilic polymer present in the polysulfone hollow fiber membrane is 3 to 20%.
【請求項4】 ポリスルホン系樹脂と親水性高分子及び
これらを共通に溶解させる溶媒からなる均一に溶解した
製膜原液を用いて、乾湿式紡糸により中空糸膜を製造す
る方法において、空中走行部の絶対湿度を0.02〜
0.3kg・水/kg・乾燥空気とすることを特徴とす
るポリスルホン系中空糸膜の製造方法。
4. A method for producing a hollow fiber membrane by dry-wet spinning, using a uniformly dissolved membrane-forming stock solution comprising a polysulfone-based resin, a hydrophilic polymer, and a solvent in which these are commonly dissolved. Absolute humidity of 0.02
A method for producing a polysulfone-based hollow fiber membrane, which comprises 0.3 kg water / kg dry air.
【請求項5】 親水性高分子がポリビニルピロリドンお
よび/またはポリエチレングリコ−ルであることを特徴
とする請求項4記載のポリスルホン系中空糸膜の製造方
法。
5. The method for producing a polysulfone-based hollow fiber membrane according to claim 4, wherein the hydrophilic polymer is polyvinylpyrrolidone and / or polyethylene glycol.
【請求項6】 空中走行部の温度が25〜60℃である
ことを特徴とする請求項4または5記載のポリスルホン
系中空糸膜の製造方法。
6. The method for producing a polysulfone-based hollow fiber membrane according to claim 4, wherein the temperature in the air running portion is 25 to 60 ° C.
【請求項7】 請求項4,5,6のいずれかに記載の方
法で製膜したことを特徴とする請求項1,2,3のいず
れかに記載のポリスルホン系中空糸膜。
7. The polysulfone-based hollow fiber membrane according to claim 1, wherein the polysulfone-based hollow fiber membrane is formed by the method according to any one of claims 4, 5, and 6.
JP11016594A 1994-04-27 1994-04-27 Polysulfone-based hollow fiber membrane and method for producing the same Expired - Lifetime JP3714686B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11016594A JP3714686B2 (en) 1994-04-27 1994-04-27 Polysulfone-based hollow fiber membrane and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11016594A JP3714686B2 (en) 1994-04-27 1994-04-27 Polysulfone-based hollow fiber membrane and method for producing the same

Publications (2)

Publication Number Publication Date
JPH07289863A true JPH07289863A (en) 1995-11-07
JP3714686B2 JP3714686B2 (en) 2005-11-09

Family

ID=14528704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11016594A Expired - Lifetime JP3714686B2 (en) 1994-04-27 1994-04-27 Polysulfone-based hollow fiber membrane and method for producing the same

Country Status (1)

Country Link
JP (1) JP3714686B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031533A1 (en) * 2001-10-04 2003-04-17 Toray Industries, Inc. Hydrophilic material and process for producing the same
JP2004121608A (en) * 2002-10-03 2004-04-22 Toyobo Co Ltd Hollow fiber membrane for dialysis liquid purification, and method for producing the same
WO2005089917A1 (en) 2004-03-22 2005-09-29 Toyo Boseki Kabushiki Kaisha Separation membrane with selective permeability and process for producing the same
JP2005334428A (en) * 2004-05-28 2005-12-08 Toyobo Co Ltd High water permeability hollow fiber membrane type hemocatharsis apparatus with superior hemocompatibility
JP2005334318A (en) * 2004-05-27 2005-12-08 Toyobo Co Ltd High strength and high water permeability hollow fiber membrane type hemocatharsis apparatus
JP2005342095A (en) * 2004-06-01 2005-12-15 Toyobo Co Ltd High water-permeable hollow fiber membrane type blood purifier
WO2006024902A1 (en) * 2004-08-06 2006-03-09 Asahi Kasei Medical Co., Ltd. Polysulfone hemodialyzer
JP2006510483A (en) * 2002-12-20 2006-03-30 ガンブロ・ルンディア・エービー Permselective membrane and method for its manufacture
JP2007000785A (en) * 2005-06-24 2007-01-11 Nikkiso Co Ltd Production method of hollow fiber module, and hollow fiber module
US7638052B2 (en) 2003-11-26 2009-12-29 Toyo Boseki Kabushiki Kaisha Polysulfone-based hollow-fiber membrane with selective permeability
US7837042B2 (en) 2004-08-10 2010-11-23 Nipro Corporation Polysulfone type selectively permeable hollow fiber membrane module and process for manufacturing the same
WO2018062451A1 (en) * 2016-09-30 2018-04-05 東レ株式会社 Separation membrane module

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6193801A (en) * 1984-07-17 1986-05-12 フレゼニウス アクチエンゲゼルシヤフト Asymmetric microporous hollow fiber and its production
JPH0194902A (en) * 1987-06-12 1989-04-13 Kuraray Co Ltd Polysulfone hollow fibrous membrane and production thereof
JPH03284326A (en) * 1990-03-29 1991-12-16 Kuraray Co Ltd Porous hollow fiber membrane
JPH04300636A (en) * 1991-03-28 1992-10-23 Toray Ind Inc Polysulfone-based permselective hollow yarn membrane and its manufacture
JPH06165926A (en) * 1992-04-29 1994-06-14 Kuraray Co Ltd Polysulfone hollow fabric membrane and production therefor
JPH07506496A (en) * 1993-03-09 1995-07-20 バクスター、インターナショナル、インコーポレイテッド Rectifier dialysis equipment, bioreactors and membranes
JPH08508935A (en) * 1994-02-09 1996-09-24 バクスター、インターナショナル、インコーポレイテッド Method for concentrating solute by rocking filter

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6193801A (en) * 1984-07-17 1986-05-12 フレゼニウス アクチエンゲゼルシヤフト Asymmetric microporous hollow fiber and its production
JPH0194902A (en) * 1987-06-12 1989-04-13 Kuraray Co Ltd Polysulfone hollow fibrous membrane and production thereof
JPH03284326A (en) * 1990-03-29 1991-12-16 Kuraray Co Ltd Porous hollow fiber membrane
JPH04300636A (en) * 1991-03-28 1992-10-23 Toray Ind Inc Polysulfone-based permselective hollow yarn membrane and its manufacture
JPH06165926A (en) * 1992-04-29 1994-06-14 Kuraray Co Ltd Polysulfone hollow fabric membrane and production therefor
JPH07506496A (en) * 1993-03-09 1995-07-20 バクスター、インターナショナル、インコーポレイテッド Rectifier dialysis equipment, bioreactors and membranes
JPH08508935A (en) * 1994-02-09 1996-09-24 バクスター、インターナショナル、インコーポレイテッド Method for concentrating solute by rocking filter

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031533A1 (en) * 2001-10-04 2003-04-17 Toray Industries, Inc. Hydrophilic material and process for producing the same
JP2004121608A (en) * 2002-10-03 2004-04-22 Toyobo Co Ltd Hollow fiber membrane for dialysis liquid purification, and method for producing the same
JP2006510483A (en) * 2002-12-20 2006-03-30 ガンブロ・ルンディア・エービー Permselective membrane and method for its manufacture
US7638052B2 (en) 2003-11-26 2009-12-29 Toyo Boseki Kabushiki Kaisha Polysulfone-based hollow-fiber membrane with selective permeability
WO2005089917A1 (en) 2004-03-22 2005-09-29 Toyo Boseki Kabushiki Kaisha Separation membrane with selective permeability and process for producing the same
US7922007B2 (en) 2004-03-22 2011-04-12 Toyo Boseki Kabushiki Kaisha Separation membrane with selective permeability and process for producing the same
JP2005334318A (en) * 2004-05-27 2005-12-08 Toyobo Co Ltd High strength and high water permeability hollow fiber membrane type hemocatharsis apparatus
JP2005334428A (en) * 2004-05-28 2005-12-08 Toyobo Co Ltd High water permeability hollow fiber membrane type hemocatharsis apparatus with superior hemocompatibility
JP2005342095A (en) * 2004-06-01 2005-12-15 Toyobo Co Ltd High water-permeable hollow fiber membrane type blood purifier
WO2006024902A1 (en) * 2004-08-06 2006-03-09 Asahi Kasei Medical Co., Ltd. Polysulfone hemodialyzer
US8828225B2 (en) 2004-08-06 2014-09-09 Asahi Kasei Medical Co., Ltd. Polysulfone hemodialyzer
US7837042B2 (en) 2004-08-10 2010-11-23 Nipro Corporation Polysulfone type selectively permeable hollow fiber membrane module and process for manufacturing the same
JP2007000785A (en) * 2005-06-24 2007-01-11 Nikkiso Co Ltd Production method of hollow fiber module, and hollow fiber module
WO2018062451A1 (en) * 2016-09-30 2018-04-05 東レ株式会社 Separation membrane module
JPWO2018062451A1 (en) * 2016-09-30 2019-07-11 東レ株式会社 Separation membrane module

Also Published As

Publication number Publication date
JP3714686B2 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
CA2094749C (en) Polysulfone-based hollow fiber membrane and process for manufacturing the same
JP3117575B2 (en) Polysulfone-based hollow fiber membrane and method for producing the same
KR100432464B1 (en) Polysulfone Hollow Fiber Semipermeable Membrane
JP2782583B2 (en) Asymmetric microporous hollow fiber
US6042783A (en) Hollow yarn membrane used for blood purification and blood purifier
CA2202969C (en) Selectively permeable hollow fiber membrane and process for producing same
JP3714686B2 (en) Polysulfone-based hollow fiber membrane and method for producing the same
JPH10108907A (en) Membrane for hemocatharsis, its preparation and module for hemocatharsis
JP2000140589A (en) Porous polysulfone film
JPH06296686A (en) Polysulfone hollow yarn membrane for medical purpose
JP2703266B2 (en) Polysulfone hollow fiber membrane and method for producing the same
JP3992185B2 (en) Method for producing hollow fiber membrane
JPH053335B2 (en)
JP3992186B2 (en) Method for producing hollow fiber membrane
JPH09308685A (en) Hollow fiber membrane for blood purification and blood purifying device
JPS63130103A (en) Polyacrylonitrile-base semipermeable membrane and manufacturing thereof
JPH07289866A (en) Polysulfone-based selective permeable membrane
Paul Polymer hollow fiber membranes for removal of toxic substances from blood
JP3334705B2 (en) Polysulfone-based selectively permeable hollow fiber membrane
JP2003033432A (en) Blood purifying film
JP4386607B2 (en) Polysulfone blood purification membrane production method and polysulfone blood purification membrane
JP2003033632A (en) Method for producing blood purifying membrane
JP2001038171A (en) Hollow fiber membrane
JP3992187B2 (en) Method for producing hollow fiber membrane
JP2000107577A (en) Production of permselective hollow fiber membranes

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040119

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041102

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050405

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050601

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20050721

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050823

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050823

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080902

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090902

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100902

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110902

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110902

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120902

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130902

Year of fee payment: 8

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130902

Year of fee payment: 8

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term